Heregulin Negatively Regulates Transcription of ErbB2/3 Receptors via an AKT-Mediated Pathway
Author:
Affiliation:
1. Greenebaum Cancer Center; University of Maryland School of Medicine; Baltimore Maryland
2. Department of Pathology; University of Maryland School of Medicine; Baltimore Maryland
Funder
NIH
Publisher
Wiley
Subject
Cell Biology,Clinical Biochemistry,Physiology
Reference57 articles.
1. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells;Aksamitiene;Cell Signal,2010
2. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas;Alimandi;Oncogene,1995
3. Amin DN Sergina N Ahuja D McMahon M Blair JA Wang D Hann B Koch KM Shokat KM Moasser MM 2010 Resiliency and vulnerability in the HER 2-HER3 tumorigenic driver. January 27, 2010 ed. Science Translational Medicine: AAAS
4. Expression of oestrogen receptors alpha and beta during the period of uterine receptivity in rat: Effect of ormeloxifene, a selective oestrogen receptor modulator;Awasthi;Acta Physiol (Oxf),2007
5. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired;Baulida;J Biol Chem,1996
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer;Cancers;2022-11-17
2. The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export;Molecular and Cellular Biology;2021-06-23
3. Microarray analysis of the expression profile of lncRNAs reveals the key role of lncRNA BC088327 as an agonist to heregulin‑1β‑induced cell proliferation in peripheral nerve injury;International Journal of Molecular Medicine;2018-03-15
4. ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC;PLOS ONE;2017-07-19
5. Engineered fusion protein-loaded gold nanocarriers for targeted co-delivery of doxorubicin and erbB2-siRNA in human epidermal growth factor receptor-2+ ovarian cancer;Journal of Materials Chemistry B;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3